541 results on '"Oprea-Lager, Daniela E."'
Search Results
152. Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim 18F‐FDG PET in DLBCL.
153. Healthy Tissue Uptake of Ga-68-Prostate-Specific Membrane Antigen, F-18-DCFPyL, F-18-Fluoromethylcholine, and F-18-Dihydrotestosterone
154. First-in-human imaging of nanoparticle entrapped docetaxel (CPC634) in patients with advanced solid tumors using Zr-89-Df-CPC634 PET/CT
155. Healthy Tissue Uptake of Ga-68-Prostate-Specific Membrane Antigen, F-18-DCFPyL, F-18-Fluoromethylcholine, and F-18-Dihydrotestosterone
156. First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
157. Impact van de 18F-DCFPyL PET/CT-scan op het behandeladvies voor patiënten met prostaatkanker en een biochemisch recidief na curatieve therapie.
158. Tumorlokalisaties op PSMA-PET/CT bij patiënten met een persisterend meetbaar PSA na een radicale prostatectomie.
159. E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET.
160. M1a prostate cancer: Results of a Dutch multidisciplinary consensus meeting.
161. Nieuwe beeldvormende technieken bij de diagnostiek van het prostaatcarcinoom
162. Lesion Detection and Interobserver Agreement with Advanced Image Reconstruction for 18F-DCFPyL PET/CT in Patients with Biochemically Recurrent Prostate Cancer
163. Reply: Quantification of 18F-DCFPyL Uptake: TBR Versus Patlak’s Analysis
164. Abstract 1415: Staging with [18F]FDG PET/CT
165. First-in-human imaging of nanoparticle entrapped docetaxel (CPC634) in patients with advanced solid tumors using 89Zr-Df-CPC634 PET/CT.
166. Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer
167. Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging?
168. Healthy Tissue Uptake of 68Ga-Prostate-Specific Membrane Antigen, 18F-DCFPyL, 18F-Fluoromethylcholine, and 18F-Dihydrotestosterone
169. Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer.
170. Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer.
171. Impact van de 18F-DCFPyL PET/CT-scan op het behandeladvies voor patiënten met prostaatkanker en een biochemisch recidief na curatieve therapie
172. Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
173. The navigating and de-risking role of 89Zr-immuno-PET in the development of biopharmaceuticals.
174. Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
175. Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer.
176. Impact of the COVID-19 crisis on imaging in oncological trials.
177. 177Lutetium PSMA-radioligandtherapie bij prostaatkanker.
178. Lesion Detection and Interobserver Agreement with Advanced Image-Reconstructions for 18F-DCFPyL PET/CT in Patients with Biochemically Recurrent Prostate Cancer.
179. Healthy Tissue Uptake of 68Ga‐Prostate Specific Membrane Antigen (PSMA), 18F‐DCFPyL, 18F‐Fluoromethylcholine (FCH) and 18F‐Dihydrotestosterone (FDHT).
180. Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group
181. Health technology assessment for PSMA-PET: striving towards a cost-effective management of prostate cancer
182. Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT
183. Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting
184. Healthy Tissue Uptake of 68Ga-Prostate-Specific Membrane Antigen, 18F-DCFPyL, 18F-Fluoromethylcholine, and 18F-Dihydrotestosterone.
185. Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences
186. A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer
187. A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer
188. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone : A Systematic Review
189. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review
190. Lymph node classification in E‑PSMA reporting guidelines for PSMA‑PET.
191. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review
192. PET-Guided Stereotactic Irradiation of Prostate Cancer Lymph Node Metastases
193. Accuracy and Precision of Partial-Volume Correction in Oncological PET/CT Studies
194. A randomized, phase II study of repeated rhenium-188-HEDP (rhenium) combined with docetaxel versus docetaxel alone in castration resistant prostate cancer (CRPC) metastatic to bone: The Taxium II trial.
195. Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer
196. Quantification of 18F-Fluorocholine Kinetics in Patients with Prostate Cancer
197. [18F]Fluoromethylcholine as a Chemotherapy Response Read-Out in Prostate Cancer Cells
198. The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases
199. Dual-Phase PET-CT to Differentiate [(18)F]Fluoromethylcholine Uptake in Reactive and Malignant Lymph Nodes in Patients with Prostate Cancer
200. Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.